1. Home
  2. CVV vs RGNT Comparison

CVV vs RGNT Comparison

Compare CVV & RGNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVD Equipment Corporation

CVV

CVD Equipment Corporation

HOLD

Current Price

$7.42

Market Cap

23.2M

Sector

Technology

ML Signal

HOLD

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$2.18

Market Cap

20.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CVV
RGNT
Founded
1982
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.2M
20.4M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
CVV
RGNT
Price
$7.42
$2.18
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
179.7K
6.5K
Earning Date
05-12-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
17.86
N/A
EPS
N/A
N/A
Revenue
$41,128,639.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
96.27
N/A
52 Week Low
$2.46
$2.01
52 Week High
$8.46
$8.35

Technical Indicators

Market Signals
Indicator
CVV
RGNT
Relative Strength Index (RSI) 63.43 19.44
Support Level $3.28 N/A
Resistance Level $8.46 $3.35
Average True Range (ATR) 1.01 0.19
MACD 0.06 -0.06
Stochastic Oscillator 72.57 14.21

Price Performance

Historical Comparison
CVV
RGNT

About CVV CVD Equipment Corporation

CVD Equipment Corp is engaged in the manufacturing of chemical vapor deposition equipment, customized gas control systems, the manufacturing of process equipment suitable for the synthesis of a variety of one-dimensional nanostructures and nanomaterials and a line of furnaces, all of which are used to produce semiconductors and other electronic components. The company operates through the segments of CVD Equipment, CVD materials, and Stainless Design Concepts, MesoScribe. It generates maximum revenue from the CVD Equipment segment. The CVD Equipment segment manufactures and sells chemical vapor deposition, physical vapor transport, and similar equipment. Company operates in USA, North America, Europe, Middle East and Africa, and Asia-Pacific.

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate (a polymer involved in tissue engineering) and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

Share on Social Networks: